Study Summary
This trial is testing whether a combination of two methods, contingency management and motivational interviewing, can help stimulant-using men who have sex with men enter into and continue PrEP care.
- Pre-Exposure Prophylaxis
- Substance Use Disorder
- Human Immunodeficiency Virus (HIV) Infection
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 4 Secondary · Reporting Duration: 6 Months
Trial Safety
Safety Progress
Side Effects for
Trial Design
4 Treatment Groups
MI+CM
1 of 4
Motivational Interviewing (MI) - Only
1 of 4
Contingency Management (CM) - Only
1 of 4
CM+MI
1 of 4
Experimental Treatment
70 Total Participants · 4 Treatment Groups
Primary Treatment: Contingency Management (CM) · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · Male Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
What is the scale of enrollment for this research project?
"Affirmative. Clinicaltrials.gov confirms that this study, first posted on October 16th 2020, is actively seeking participants for enrollment. A total of 70 people need to be recruited from 1 clinical site." - Anonymous Online Contributor
Are there any vacancies available to participants in this research program?
"As obvious from clinicaltrials.gov, this trial is presently trying to find eligible applicants. It was originally published on October 16th 2020 and the most recent iteration of it occurred on October 13th 2022." - Anonymous Online Contributor